IP Library › Assignment 044632/0113
Patent Assignment
Reel/Frame 044632/0113

Merger

Recorded: 2018-01-16 Pages: 19
Assignor
IMMVARX, INC.
Executed: 2009-11-25
Assignee
MISSION THERAPEUTICS, INC.
2385 SANTA ANA STREET, PALO ALTO, CALIFORNIA, 94303
Covered Properties (4)
Cancer Marker Protein and Peptides Thereof
Patent: 6,166,176 →
Application: 09/040,485 →
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 6,727,080 →
Application: 09/659,521 →
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 7,329,743 →
Application: 10/830,702 →
Publication: US 2005/0208508
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 7,635,759 →
Application: 12/029,113 →
Publication: US 2008/0249284
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 9, 2000
From: RADOSEVICH, JAMES
To: IMMVARX, INC.
Reel/Frame 011124/0233 →
Assignment of Assignor's Interest Dec 4, 2000
From: RADOSEVICH, JAMES
To: IMMVARX, INC.
Reel/Frame 011359/0162 →
Confirmatory License Nov 13, 2003
From: RADOSEVICH, JAMES A.
To: DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 014675/0612 →
Assignment of Assignor's Interest Jun 10, 2008
From: RADOSEVICH, JAMES A.
To: IMMVARX, INC.
Reel/Frame 021074/0628 →
Assignment of Assignor's Interest Jan 16, 2018
From: MISSION THERAPEUTICS, INC.
To: OPUS CRYSTAL HOLDINGS LIMITED
Reel/Frame 044632/0246 →